| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.9 |
| mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
-0.0045 |
0.9 |
| mRNA |
FMK |
GDSC1000 |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0041 |
0.9 |
| mRNA |
TPCA-1 |
GDSC1000 |
pan-cancer |
AAC |
0.0033 |
0.9 |
| mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
| mRNA |
PF-543 |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0041 |
0.9 |
| mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.0041 |
0.9 |